The highest-cost patients need the tightest data
Cardiovascular disease drives more healthcare spending than any other condition category. Your patients are on statins, antihypertensives, anticoagulants, and antiplatelet agents — each with adherence thresholds that directly affect outcomes and quality scores. When a CHF patient hits the ED, it costs $15,000. Preventing that visit is worth more than treating it.
Glance tracks BP control, statin adherence, anticoagulation PDC, cardiac-specific HCC codes, and utilization patterns so you can intervene before the next admission.
Schedule a Demo See FeaturesCardiology-specific analytics
Cardiovascular patients are expensive when uncontrolled and highly manageable when tracked closely. Glance gives you the tracking tools.
BP Control Tracking
Track BP control rates across your entire cardiology panel. Identify patients above 140/90, see trending over the last 12 months, and flag patients who have not had a BP reading in over 90 days. HEDIS CBP measure compliance calculated automatically from clinical data.
Statin & Anticoagulant Adherence
Proportion of Days Covered for statins, antihypertensives, and anticoagulants. Identify patients below the 80% PDC threshold. For your AFib patients on DOACs or warfarin, track gaps in anticoagulation that increase stroke risk and drive avoidable utilization.
Cardiac HCC Coding
Capture the full spectrum of cardiac HCCs: CHF by severity (HCC 85/86), atrial fibrillation, cardiomyopathy, valvular disease, peripheral vascular disease, and unstable angina. Surface suspected conditions from echocardiogram results, stress test findings, and procedure claims that have not been coded on the problem list.
Utilization & Readmission Tracking
Track ED visits and inpatient admissions for CHF exacerbation, ACS, arrhythmia, and other cardiac events across your panel. Identify patients with repeat admissions who need intensified outpatient management. See the financial impact of avoidable utilization on your VBC contract.
High-Cost Patient Analytics
Cardiology patients disproportionately drive total cost of care. Track PMPM costs by diagnosis, identify the top 5% of spenders, and model the financial impact of preventing one CHF admission or one stroke. Reimbursement benchmarking for cardiac procedures against regional and national rates.
Quality measures that matter in cardiology
BP Control
HEDIS Controlling Blood Pressure. The single most impactful measure for cardiology panels.
Statin Therapy
HEDIS Statin Therapy for Patients with Cardiovascular Disease. Adherence and prescribing rates.
Medication Adherence
Proportion of Days Covered for statins, RAS antagonists, and anticoagulants. Triple-weighted in Star Ratings.
Total Cost of Care
Per-member-per-month cardiac spend against benchmarks. Where your VBC shared savings are won or lost.
